Treatment With Full‐Spectrum Cannabidiol Oil Improved the Pathological Findings of Dystrophic Mutant Mice
Muscle & Nerve · 2025-04 · 71 (4) · 651-661
DOI: 10.1002/mus.28337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, online erschienen am 22.01.2025. Verfasst von Laís Leite Ferreira und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Federal University of Alfenas (UNIFAL-MG), Alfenas, Brazil. Hauptthemen laut MEDLINE: Cannabidiol, Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Council for Scientific and Technological Development (CNPq), Coordination of Superior Level Staff Improvement (CAPES), Research Support Foundation of the State of Minas Gerais (FAPEMIG).
Abstract (Originalsprache)
Introduction/Aims Duchenne muscular dystrophy (DMD) is caused by pathogenic variants in the DMD gene, making muscle fibers susceptible to contraction‐induced membrane damage. Given the potential beneficial action of cannabidiol (CBD), we evaluated the in vitro effect of full‐spectrum CBD oil on the viability of dystrophic muscle fibers and the in vivo effect on myopathy of the mdx mouse, a DMD model.
Methods
In vitro, dystrophic cells from the mdx mouse were treated with full‐spectrum CBD oil and assessed with cell viability and cytotoxic analyses. In vivo, fourteen‐day‐old mdx mice received 10 mg/kg/day of the full‐spectrum CBD oil for 14 days. We analyzed creatine kinase (CK) levels, liver damage markers, and histopathology of the diaphragm (DIA) and quadriceps (QUA [myonecrotic fibers with positive IgG staining, regenerated fibers/central nuclei, the minimum Feret's diameter, the fibrosis area, the inflammatory area, the presence of macrophages, and NF‐kappa B content]).
Results
In vitro treatment with full‐spectrum CBD oil showed a dose‐dependent cytotoxic effect; however, in vivo 10 mg/kg treatment was safe and effectively improved DMD histopathological assessment parameters in DIA and QUA: reduction of central nuclei: 1.7% ± 2.0% versus 22.4% ± 5.3% and 11.1% ± 10.7% versus 32.3% ± 4.6%; reduction of IgG+ myofibers: 0.6% ± 0.7% versus 8.4% ± 1.6% and 0.9% ± 0.3% versus 7.5% ± 1.0%; increase in myofiber size: 85.2 ± 3.2 versus 64.3 ± 4.0 μm and 106.5 ± 8.6 versus 81.2 ± 4.8 μm; decrease in inflammatory area: 6.2% ± 2.7% versus 15.1% ± 2.6% and 5.3 ± 4.1 versus 17.3% ± 2.8%; reduced macrophage area: 0.05% ± 0.1% versus 10.8% ± 4.3% and 1.0% ± 0.7% versus 10.3% ± 4.9%; NF‐κB levels: 0.6% ± 0.1% versus 1.7% ± 0.2% and 1.7% ± 0.1% versus 5.2% ± 2.1%; and fibrosis: 5.6% ± 1.8% versus 12.0% ± 3.7% and 1.3% ± 0.5% versus 4.7% ± 1.5%. It also reduced serum CK.
Discussion
Full‐spectrum CBD oil may represent a promising new approach to treating DMD, but its potential toxicity must be considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy, Federal University of Alfenas (UNIFAL-MG), Alfenas, Brazil.
- Department of Structural Biology, Federal University of Alfenas (UNIFAL-MG), Alfenas, Brazil.
- Natural Sciences Institute, Federal University of Alfenas (UNIFAL-MG), Alfenas, Brazil.
- Motor Sciences Institute, Federal University of Alfenas (UNIFAL-MG), Alfenas, Brazil.
ORCID-Profile: Laís Leite Ferreira, Beatriz Godinho Nascimento, Túlio de Almeida Hermes
Förderung
- National Council for Scientific and Technological Development (CNPq)
- Coordination of Superior Level Staff Improvement (CAPES)
- Research Support Foundation of the State of Minas Gerais (FAPEMIG)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
Zitieren
APA
Ferreira, L. L., Gomes, F. S., Nascimento, B. G., Corsini, W., Dos Reis, L. F. C., Oliveira-Silva, J. M., da Silva, J. R. T., da Silva, M. L., Gamero, A. M. C., & Hermes, T. A. (2025). Treatment With Full‐Spectrum Cannabidiol Oil Improved the Pathological Findings of Dystrophic Mutant Mice. Muscle & Nerve, 71(4), 651-661. https://doi.org/10.1002/mus.28337
Vancouver
Ferreira LL, Gomes FS, Nascimento BG, Corsini W, Dos Reis LFC, Oliveira-Silva JM, et al. Treatment With Full‐Spectrum Cannabidiol Oil Improved the Pathological Findings of Dystrophic Mutant Mice. Muscle & Nerve. 2025;71(4):651-661. doi:10.1002/mus.28337
BibTeX
@article{Ferreira2025,
author = {Ferreira, Laís Leite and Gomes, Fabricio Souza and Nascimento, Beatriz Godinho and Corsini, Wagner and Dos Reis, Luis Felipe Cunha and Oliveira-Silva, João Marcos and da Silva, Josie Resende Torres and da Silva, Marcelo Lourenço and Gamero, Angel Maurício Castro and Hermes, Túlio de Almeida},
title = {Treatment With Full‐Spectrum Cannabidiol Oil Improved the Pathological Findings of Dystrophic Mutant Mice},
journal = {Muscle & Nerve},
year = {2025},
volume = {71},
number = {4},
pages = {651--661},
doi = {10.1002/mus.28337}
}
EUVIMED